Accretion Nutraveda Ltd
Accretion Nutraveda Ltd (ANL) last traded at ₹288, a market capitalisation of ₹209 crore, on a P/E of 41.1. Over the past 52 weeks the stock has ranged between ₹150 and ₹313. Accretion Nutraveda Ltd last reported results for the quarter ended Mar 2026, with sales of ₹19.54 crore and net profit of ₹2.69 crore. Accretion Nutraveda Ltd’s annual general meeting is scheduled for 26 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.
Accretion Nutraveda Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Accretion Nutraveda Ltd quarterly results
| ₹ crore | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 10.85 | 14.06 | 19.54 |
| Expenses | 8.27 | 10.76 | 15.98 |
| Operating profit | 2.58 | 3.3 | 3.56 |
| OPM % | 23.78% | 23.47% | 18.22% |
| Other income | 0 | 0 | 0.11 |
| Interest | 0.26 | 0.26 | 0.27 |
| Depreciation | 0.11 | 0.17 | 0.1 |
| Profit before tax | 2.21 | 2.87 | 3.3 |
| Tax % | 22.17% | 18.47% | 18.48% |
| Net profit | 1.72 | 2.33 | 2.69 |
| EPS (₹) | 35.32 | 4.38 | 3.72 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Accretion Nutraveda Ltd annual results
| ₹ crore | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 2.89 | 5.01 | 16 | 33.59 |
| Operating profit | 0.62 | 1.23 | 3.71 | 6.89 |
| OPM % | 21.45% | 24.55% | 23.19% | 20.51% |
| Net profit | 0.28 | 0.82 | 2.5 | 5.07 |
| EPS (₹) | 7.78 | 22.78 | 51.33 | 7.00 |
TTM is the trailing twelve months to the most recent quarter.
Accretion Nutraveda Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 127%
- TTM
- 110%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 163%
- TTM
- 103%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 35%
- Last Year
- 25%
Accretion Nutraveda Ltd shareholding pattern
Promoters held 73.48% at Jun 2026, broadly unchanged since Mar 2026. FIIs 1.08% and DIIs 6.10%.
| % held | Mar 2026 | Jun 2026 |
|---|---|---|
| Promoters | 73.48% | 73.48% |
| FIIs | 1.08% | 1.08% |
| DIIs | 7.00% | 6.10% |
| Public | 18.43% | 19.34% |
| No. of shareholders | 427 | 396 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Accretion Nutraveda Ltd’s AGM?
Accretion Nutraveda Ltd’s annual general meeting is scheduled for 26 Aug 2026.
- AGM5th Annual General Meeting and E-Voting
- AGM5th Annual General Meeting to adopt financial statements, re-appoint a director, and approve remuneration revisions for multiple directors.
See the full results calendar for every Indian company reporting in the next 30 days.
Accretion Nutraveda Ltd corporate filings
- Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''Listing Regulations'')Company Updatelow impact
Cruxal's analysis: Accretion Nutraveda Ltd has filed a disclosure under Regulation 30 of the SEBI Listing…
Read the full analysis - Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: Accretion Nutraveda Ltd has published a newspaper advertisement regarding the convening…
Read the full analysis - Notice Of The 5Th AGM Of The CompanyAGM/EGMlow impact
Cruxal's analysis: Accretion Nutraveda Limited has scheduled its 5th Annual General Meeting for 27 August…
Read the full analysis - Reg. 34 (1) Annual Report.Otherslow impact
Cruxal's analysis: Accretion Nutraveda Ltd has filed its Annual Report for the financial year 2025-26. This…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Accretion Nutraveda Ltd
Cruxal reads every Accretion Nutraveda Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.